Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canopy Growth Corporation - Common Shares (NQ: CGC )

1.430 -0.070 (-4.67%)
Streaming Delayed Price Updated: 2:29 PM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Canopy Growth Corporation - Common Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
77 78 Next >
Canopy Growth's Strategy To Deleverage Balance Sheet By $437M And Enhance Financial Flexibility
Canopy Growth Corp. (TSX: WEED) (NASDAQ: CGC) announced measures to enhance its financial flexibility and reduce its debt. 
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. 
Via Benzinga
Why Canopy Growth Stock Is Tanking Today?
Via Benzinga
Why Canopy Growth Stock Is Flying High Today
Any good news goes a long way for this beaten-down pot stock. 
Via The Motley Fool
What's Going On With Canopy Growth Stock Tuesday?
Canopy Growth Corporation (NASDAQ: CGC) shares are moving higher on heavy trading volume Tuesday. What To Know: 
Via Benzinga
Things Have Gone From Bad to Worse for Canopy Growth
Investors should resist the temptation to buy the stock just because it appears cheap. 
Via The Motley Fool
Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
Via Benzinga
Canopy Growth's Going-Concern Risk: Is the Company in Danger of Going Out of Business?
The company's financials continue to deteriorate. 
Via The Motley Fool
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important July 24 Deadline in Securities Class Action - CGC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Eight Capital Analyst Believes Canopy Should Not Be Valued As A Going Concern, Price Target $0
TerrAscend Corp. (OTC: TSNDF) has had a watershed moment, and Canopy Growth (NASDAQ: CGC) reaches $0 price target. Welcome to our latest Trade to Black podcast. 
Via Benzinga
Why Shares of Canopy Growth Are Dropping Wednesday
An analyst downgraded the stock to a $0 price target. 
Via The Motley Fool
Cannabis Stock Gainers And Losers From July 11, 2023
Via Benzinga
CANOPY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Canopy Growth Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
The Canadian Cannabis Report - Monday July 10
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 15 stocks. 
Via Talk Markets
Conservative "Cannabis" Stocks Up Slightly Last Week
Our Conservative 
Via Talk Markets
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Canadian Cannabis LPs Index Advanced This Week
Latest news: Analyst gives Canopy a $0 price target; Organigram completes a 4-for-1 consolidation of its shares. 
Via Talk Markets
Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 7, 2023
Via Benzinga
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
4 Concerning Stats About Some of Canada's Top Cannabis Markets
These numbers should make you think twice about buying Canadian pot stocks. 
Via The Motley Fool
Should You Buy This Blue Chip Stock for Dividend Growth?
The company is a leader within the alcoholic beverage industry. 
Via The Motley Fool
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
7 Dying Stocks to Sell in July While You Still Can
Investors should sell dying stocks from these troubled companies, many of which have underperformed the market for years. 
Via InvestorPlace
Bearish Sentiment Across The Cannabis Space - Check Full Movers For July 6, 2023
Via Benzinga
What's Going On With Canopy Growth Shares Thursday?
Canopy Growth Corporation (NASDAQ: CGC) shares are trading lower on Thursday following a short-lived rally earlier in the week. What To Know: 
Via Benzinga
CANOPY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Canopy Growth Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Cannabis Stock Movers For July 5, 2023
Via Benzinga
Constellation Brands - A Diversified Tale Of Making The Best Of A Slow Growth Industry
Unlike Invesco QQQ Trust (NASDAQ: QQQ) that is all about the tech stocks changing the world, the S&P 500 is more about what makes the world, as as its members, also held by SPDR S&P 500 ETF Trust... 
Via Benzinga
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in... 
Via Benzinga
What's Going On With Canopy Growth Stock Wednesday?
Canopy Growth Corporation (NASDAQ: CGC) shares are trading lower Wednesday.  The stock appears to be pulling back after rising over 20% on Monday. 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
77 78 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.